Gastrointestinal stromal tumors: a review of the literature.
Gastrointestinal stromal tumors are mesenchymal neoplasms with a spectrum of histologic appearances and biologic activity. The morphologic classification of these lesions has evolved over time, and molecular analysis has led to a better understanding of their nature. The histologic differential diagnosis for these lesions is broad and includes many spindle cell lesions of the gastrointestinal tract, including neoplasms of true smooth muscle and neural origin, proliferating fibrous lesions, metastatic neoplasms, and primary sarcomas of vascular and adipose origin. Immunohistochemical studies that include CD117 have become invaluable in the classification of mesenchymal lesions arising in the gastrointestinal tract. Treatment of gastrointestinal stromal tumors has historically been involved surgery, but the use of the chemotherapeutic agent imatinib mesylate for advanced disease has made accurate classification even more important. The molecular features have not only allowed us to understand the pathogenesis of these tumors but also have proven to be associated with response to kinase inhibitors.
Laurini
Javier A
JA
Department of Pathology, University of South Alabama Medical Center, Mobile, AL 36617, USA. jlaurini@usouthal.edu
Carter
J Elliot
JE
D003937:Diagnosis, Differential; D005770:Gastrointestinal Neoplasms / Q000175:diagnosis / Q000276:immunology / Q000473:pathology*; D046152:Gastrointestinal Stromal Tumors / Q000175:diagnosis / Q000276:immunology / Q000473:pathology*; D006801:Humans; D016130:Immunophenotyping; D011379:Prognosis; D019009:Proto-Oncogene Proteins c-kit / Q000378:metabolism
D019009:Proto-Oncogene Proteins c-kit